Global Cancer Gene Therapy Market Size Study, By End-User (Diagnostics Centers, Hospitals, Research Institutes), By Therapy (Oncolytic Virotherapy, Gene induced immunotherapy, Gene transfer and others), and Regional Forecasts, 2017-2025

For discount/customization and buying a particular chapter, write to us at sales@bizwitresearch.com

Global Cancer Gene Therapy Market industry valued approximately USD 0.2 billion in 2016 is anticipated to grow with a healthy growth rate of more than 35.1% over the forecast period 2017-2025. The major factors driving the growth are rising need for Cancer Gene Therapy worldwide, increase in prevalence of cancer, increase in geriatric population, increase in funding for R&D activities of cancer gene therapy and favorable government regulations.

Global Cancer Gene Therapy MarketThe objective of the study is to define market sizes of different segments & countries in previous years and to forecast the values to the next eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry with respect to each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as drivers & restraining factors which will define the future growth of the market. Additionally, it will also incorporate the opportunities available in micro markets for stakeholders to invest, detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

End-User:

  • Diagnostics Centers
  • Hospitals
  • Research Institutes

Therapy:

  • Oncolytic Virotherapy
  • Gene Induced Immunotherapy
  • Gene transfer
  • Others

Regions:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • China
    • India
    • Japan
  • Latin America
    • Brazil
    • Mexico
  • Rest of the World

Furthermore, the years considered for the study are as follows:

Historical year – 2015

Base year – 2016

Forecast period – 2017 to 2025

Some of the key manufacturers involved in the market are OncoGenex Pharmaceuticals, Adaptimmune,Merck, Bluebird bio, Inc,GlaxoSmithKline, Shanghai Sunway Biotech, BioCancell, Celgene, Shenzhen SiBiono GeneTech and SynerGene Therapeutics.Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and focuses on continuous technology innovations are also strategies adopted by the major players. The companies are also trying to dominate the market by investing in research and development.

Target Audience of the Cancer Gene Therapy Market Study

  • Key Consulting Companies & Advisors
  • Large, medium-sized, and small enterprises
  • Venture capitalists
  • Value-Added Resellers (VARs)
  • Third-party knowledge providers
  • Investment bankers
  • Investors

 

 Chapter 1.           Research Methodology

1.1.         Research Process

1.1.1.     Data Mining

1.1.2.     Analysis

1.1.3.     Market Estimation

1.1.4.     Validation

1.1.5.     Publishing

1.2.         Research Assumption

Chapter 2.           Global Cancer Gene Therapy Market Definition & Scope

2.1.         Objective of The Study

2.2.         Market Definition

2.3.         Scope of The Study

2.4.         Years Considered for The Study

2.5.         Currency Conversion Rates

2.6.         Report Limitation

Chapter 3.           Executive Summary

3.1.         Key Trends

3.2.         Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)

Chapter 4.           Global Cancer Gene Therapy Industry Dynamics

4.1.         Growth Prospects

4.1.1.     Drivers

4.1.2.     Restraints

4.1.3.     Opportunities

4.2.         Industry Analysis

4.2.1.     Porter’s 5 Force Model

4.2.2.     PEST Analysis

4.2.3.     Value Chain Analysis

4.3.         Analyst Recommendation & Conclusion

Chapter 5.           Global Cancer Gene Therapy Market by End-User

5.1.         Market Snapshot

5.2.         Cancer Gene Therapy Market, Sub Segment Analysis

5.2.1.     Diagnostics Centers

5.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

5.2.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

5.2.2.     Hospitals

5.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

5.2.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

5.2.3.     Research Institutes

5.2.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

5.2.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 6.           Global Cancer Gene Therapy Market by Therapy

6.1.         Market Snapshot

6.2.         Cancer Gene Therapy Market, Sub Segment Analysis

6.2.1.     Oncolytic Virotherapy

6.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.2.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.2.2.     Gene Induced Immunotherapy

6.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.2.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.2.3.     Gene Transfer

6.2.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.2.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.2.4.     Others

6.2.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.2.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 7.           Global Cancer Gene Therapy Market, Regional Analysis

7.1.         Cancer Gene Therapy Market, Regional Market Snapshot (2015-2025)

7.2.         North America Cancer Gene Therapy Market Snapshot

7.2.1.     U.S. Cancer Gene Therapy Market Size Estimates & Forecasts, 2015-2025 (USD Billion)

7.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.2.1.2. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.2.1.3. Therapy breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.2.2.     Canada Cancer Gene Therapy Market Size Estimates & Forecasts, 2015-2025 (USD Billion)

7.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.2.2.2. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.2.2.3. Therapy breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.         Europe Cancer Gene Therapy Market Snapshot

7.3.1.     U.K. Cancer Gene Therapy Market Size Estimates & Forecasts, 2015-2025 (USD Billion)

7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.3.1.2. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.1.3. Therapy breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.2.     Germany Cancer Gene Therapy Market Size Estimates & Forecasts, 2015-2025 (USD Billion)

7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.3.2.2. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.2.3. Therapy breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.3.     France Cancer Gene Therapy Market Size Estimates & Forecasts, 2015-2025 (USD Billion)

7.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.3.3.2. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.3.3. Therapy breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.4.     Rest of Europe Cancer Gene Therapy Market Size Estimates & Forecasts, 2015-2025 (USD Billion)

7.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.3.4.2. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.4.3. Therapy breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.4.         Asia Cancer Gene Therapy Market Snapshot

7.4.1.     China Cancer Gene Therapy Market Size Estimates & Forecasts, 2015-2025 (USD Billion)

7.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.4.1.2. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.4.1.3. Therapy breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.4.2.     India Cancer Gene Therapy Market Size Estimates & Forecasts, 2015-2025 (USD Billion)

7.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.4.2.2. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.4.2.3. Therapy breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.4.3.     Japan Cancer Gene Therapy Market Size Estimates & Forecasts, 2015-2025 (USD Billion)

7.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.4.3.2. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.4.3.3. Therapy breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.4.4.     Rest of Asia Pacific Cancer Gene Therapy Market Size Estimates & Forecasts, 2015-2025 (USD Billion)

7.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.4.4.2. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.4.4.3. Therapy breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.5.         Latin America

7.5.1.     Brazil Cancer Gene Therapy Market Size Estimates & Forecasts, 2015-2025 (USD Billion)

7.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.5.1.2. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.5.1.3. Therapy breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.5.2.     Mexico Cancer Gene Therapy Market Size Estimates & Forecasts, 2015-2025 (USD Billion)

7.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.5.2.2. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.5.2.3. Therapy breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.6.         Rest of The World Cancer Gene Therapy Market Snapshot

7.6.1.     Market estimates & forecasts, 2015-2025 (USD Billion)

7.6.2.     End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.6.3.     Therapy breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 8.           Competitive Intelligence

8.1.         Company Market Share (Subject to Data Availability)

8.2.         Top Market Strategies

8.3.         Company Profiles

8.3.1.     OncoGenex Pharmaceuticals

8.3.1.1. Overview

8.3.1.2. Financial (Subject to Data Availability)

8.3.1.3. Product Summary

8.3.1.4. Recent Developments

8.3.2.     Adaptimmune

8.3.3.     Merck

8.3.4.     Bluebird bio,Inc

8.3.5.     GlaxoSmithKline

8.3.6.     Shanghai Sunway Biotech

8.3.7.     BioCancell

8.3.8.     Celgene

8.3.9.     Shenzhen SiBiono GeneTech

8.3.10.   SynerGene Therapeutics

The research for Global Cancer Gene Therapy market focuses deeply on the entire value chain of the market. However, the market size estimates are purely based on the consumer side of the value chain wherein the market sizes have been calculated by analyzing the average demand for Cancer Gene Therapy across various end-uses such as the hospitals, research institutes and diagnostic centers.

The revenue for global Cancer Gene Therapy market is calculated as sum market sizes of different segments such as end users, therapy and regions. Further, some other key data points considered to calculate the revenue for global Cancer Gene Therapy market include:

  • Revenues from key companies
  • Key company market share analysis
  • Adoption across end-users
  • Regulatory Scenario

An extensive primary and secondary research has been conducted on key industry people, through questionnaires, telephonic conversations, email conversations, and interviews to verify the market estimations. Various government websites/portals and paid data sources are considered as a key source of secondary research.

We utilize a combination of bottom-up & top-down methodology for market estimations & forecasts. Additionally, we employ data triangulation techniques to verify each of the market estimates and forecasts through primary interviews and feedbacks.

All the estimates are derived from simulation models which is our proprietary technique. Each of these models is different from each other are a combination of correlation, regression and time series analysis. Each of these models is basically divided into two types namely economic and technological. Economical models are used to determine short-term market estimates and technological models are used for long-term estimates & forecasts. 

 


We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.

Buy Now


Single User – $3,150

Enterprise License – $5,550


Loading…